Thymosin Alpha-1 — 5 mg

28-amino-acid immunomodulatory peptide (Tα1), marketed as an approved drug in some countries. Studied for effects on T-cell maturation, Toll-like-receptor signaling, and dendritic-cell function.

Research Focus:

• Immune Cell Research — Studied for T-cell maturation and differentiation.

• Immune Signaling Research — Investigated for TLR2/TLR9 modulation.

• Immune Balance Research — Examined for innate/adaptive immune balance.

• Immune Activation Research — Studied for dendritic-cell activation.

• Cytokine Research — Studied for cytokine-network regulation.

• Host Defense Research — Investigated in antiviral and defense models.

• Immune Aging Research — Studied within immune-aging (immunosenescence) research.

RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION

Not for human or veterinary use. Sold exclusively as a reference material for in-vitro and in-vivo laboratory research. Not evaluated by the FDA; not intended to diagnose, treat, cure, or prevent any disease.